Drug Pipeline

Cabotegravir Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
3
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-30 NCT07473778
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention		 Trial sites expanded: 10 -> 17 locations
Active Studies by Phase
Phase 4
1
Phase 2
1
Phase 1/2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07199335 Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs HIV Recruiting
Phase 2
NCT05996471 A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir… HIV Infections Active, Not Recruiting
Phase 1/2
NCT07275606 A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1 HIV Infections Recruiting
Not specified
NCT07473778 Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention HIV Infections Recruiting
Sponsors Running Cabotegravir Trials
ViiV Healthcare (2) Massachusetts General Hospital (1) Gilead Sciences (1)
Get alerts when Cabotegravir trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free